Organization
Zhejiang University
50 clinical trials
Clinical trial
A Multicenter, Multi-cohort, Randomized, Phase II Study of Irinotecan Liposome Combined With 5-FU / LV and Oxaliplatin for Resectable Pancreatic Cancer With or Without AddebelizumabStatus: Not yet recruiting, Estimated PCD: 2026-01-20
Clinical trial
A Multicenter, Randomized, Controlled Study of S-1 Combined With Oxaliplatin by Arterial Infusion Plus PD-1 Antibody Versus Conventional SOX Chemotherapy Plus PD-1 Antibody for Locally Advanced Gastric CancerStatus: Recruiting, Estimated PCD: 2026-06-01
Clinical trial
Clinical Protocol of Self-Controlled Study on the Effects of Sertraline on Depression in Parkinson's DiseaseStatus: Completed, Estimated PCD: 2013-08-01
Clinical trial
Prospective, Single-arm, Multicenter Clinical Study on Haploidentical Hematopoietic Stem Cell Transplantation in Patients With MRD Positive CD19+ALL Treated With Conditioning Regimens Containing BlinatumomabStatus: Recruiting, Estimated PCD: 2025-01-01
Clinical trial
A Randomized, Open-label, Phase 3 Trial Evaluating Adjuvant Transarterial Chemoembolization for TNM Stage I and II Hepatocellular Carcinoma Recurrence After Curative ResectionStatus: Completed, Estimated PCD: 2023-05-13
Clinical trial
A Study of CD19-BAFF CAR-T Cells Therapy for Patients With Relapsed and/or Refractory B-cell ALL and B-cell NHLStatus: Recruiting, Estimated PCD: 2027-05-30
Clinical trial
Efficacy and Safety of Induction and Tapering Therapy With Tofacitinib and Glucocorticoid in Patients With Polymyalgia Rheumatica (ITTG PMR): An Open-label 52-week Randomized Controlled TrialStatus: Not yet recruiting, Estimated PCD: 2025-09-30
Clinical trial
Clinical Trial for the Safety and Efficacy of CD19 CAR-T Therapy for Patients With B-cell Non-Hodgkin's LymphomaStatus: Recruiting, Estimated PCD: 2026-12-20
Clinical trial
Clinical Study to Evaluate the Safety and Efficacy of iPSC -NK Cells Targeting CLL1 or CD33 in Patients With Relapsed/Refractory AMLStatus: Recruiting, Estimated PCD: 2026-03-31
Clinical trial
Survival Analysis of TACE Monotherapy vs. Combination Therapy in BCLC B and C Stage Hepatocellular Carcinoma: A Retrospective Cohort StudyStatus: Completed, Estimated PCD: 2023-03-31
Clinical trial
Efficacy and Safety of Intravenous YOLT-201 for Transthyretin Amyloidosis CardiomyopathyStatus: Recruiting, Estimated PCD: 2024-10-16
Clinical trial
TAS-102 Combined With Anlotinib in Patients With Metastatic Gastric Cancer Refractory to Standard Treatments (THALIA): a Prospective Single-arm Phase II StudyStatus: Recruiting, Estimated PCD: 2024-12-31
Clinical trial
A Clinical Study to Evaluate Safety and Efficacy of C-CAR031 Armored CAR-T Cell Injection in Treatment of Advanced Hepatocellular CarcinomaStatus: Recruiting, Estimated PCD: 2026-05-01
Clinical trial
An Exploratory Study to Evaluate the Safety and Efficacy of Peptide Receptor Radionuclide Therapy With 177Lu-EB-FAPI in Patients With Advanced Cholopancreatic TumorsStatus: Recruiting, Estimated PCD: 2024-06-30
Clinical trial
Clinical Study of Targeting CD19-BAFF CAR-T Cells in the Treatment of Autoimmune DiseasesStatus: Recruiting, Estimated PCD: 2027-02-01
Clinical trial
NKG2D CAR-NK Cell Therapy in Patients With Refractory Metastatic Colorectal CancerStatus: Recruiting, Estimated PCD: 2024-12-31
Clinical trial
Clinical Trial for the Safety and Efficacy of Anti-CD7 Chimeric Antigen Receptor Cell Therapy for Patients With Relapsed or Refractory CD7 Positive Hematological MalignancyStatus: Recruiting, Estimated PCD: 2023-12-30
Clinical trial
Autologous T Cells Modified by Chimeric Antigen Receptor Targeting EpCAM for Clinical Research on Advanced Digestive System MalignanciesStatus: Recruiting, Estimated PCD: 2024-12-30
Clinical trial
A Phase ll,Single-center,Single-arm Clinical Study of Low-dose Chidamide Maintenance Therapy After Allogeneic Hematopoietic Stem Cell Transplantation for T-cell Acute Lymphoblastic Leukemia or T-cell LymphomasStatus: Recruiting, Estimated PCD: 2025-06-01
Clinical trial
Study on Therapeutic Effect of Combination of Anti-PD-1 Antibody and Chemotherapy in Locally Advanced or Borderline Resectable Pancreatic Cancer Patients: A Randomized Clinical TrialStatus: Recruiting, Estimated PCD: 2023-12-01
Clinical trial
Surufatinib and Toripalimab Combined With Chemotherapy for Second-line Treatment of Advanced RAS/BRAF Mutant and Microsatellite Stable Colorectal CancerStatus: Recruiting, Estimated PCD: 2025-06-01
Clinical trial
A MulticenterOpen LableDose Escalat Tion and Dose Expansion Clinical Study to Evaluate the Safety, Tolerance and Ini Itial Effectiveness of WTX212A Injection in Patients With Unresectable or Metasta Atic Advanced Solid TumorsStatus: Recruiting, Estimated PCD: 2024-08-30
Clinical trial
Camrelizumab and Apatinib Combined With Chemotherapy (mFOLFOX6) in Neoadjuvant Therapy for Locally Advanced Colon CancerStatus: Recruiting, Estimated PCD: 2024-12-30
Clinical trial
Clinical Trial for the Safety and Efficacy of Non-viral PD1 Integrated Anti-PSMA Chimeric Antigen Receptor T Cells in the Treatment of Refractory Castrate-Resistant Prostate CancerStatus: Completed, Estimated PCD: 2022-06-30
Clinical trial
An Open, Dose Escalation/Dose Exploration, Phase I Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Single/Multiple Infusion of CT0180 Injection in Patients With Advanced Hepatocellular CarcinomaStatus: Recruiting, Estimated PCD: 2024-06-01
Clinical trial
A Phase I Clinical Study to Assess the Safety and Efficacy of CD70-targeted CAR-T in the Treatment of CD70-positive Refractory or Relapsed Solid TumorsStatus: Not yet recruiting, Estimated PCD: 2027-04-21
Clinical trial
A Study to Evaluate the Safety, Tolerability, Preliminary Efficacy, Pharmacodynamics and Immunogenicity of Universal CNK-UT Cells in Patients With Advanced Solid Tumors.Status: Recruiting, Estimated PCD: 2025-05-01
Clinical trial
Clinical Study to Evaluate the Safety and Efficacy of iPSC NK Cells Targeting CLL1 in Patients With Relapsed/Refractory AMLStatus: Recruiting, Estimated PCD: 2026-08-31
Clinical trial
The IIT Study of Evaluation of Platelet-coupled IL-2 Cell Injection (P-IL-2) Single Agent and With Anti-PD-1 Monoclonal Antibody on the Safety, Tolerance and Preliminary Effectiveness in Patients With Advanced Malignant Solid TumorsStatus: Recruiting, Estimated PCD: 2024-12-31
Clinical trial
A Study on the Safety and Efficacy of Donafinib Combined With Anti-PD-1 Antibody as Adjuvant Therapy for HCC Patients With High Risks of RecurrenceStatus: Recruiting, Estimated PCD: 2023-12-30
Clinical trial
A Study on the Safety and Efficacy of Chimeric Antigen Receptor T Cells in the Treatment of Recurrent/Refractory Neuromyelitis OpticaStatus: Recruiting, Estimated PCD: 2026-04-30
Clinical trial
An Exploratory Clinical Study of GC012F Injection for the Treatment of Refractory Generalized Myasthenia GravisStatus: Recruiting, Estimated PCD: 2026-06-01
Clinical trial
Study on Therapeutic Effect of Combination of Envafolimab, Lenavatinib and TACE in Advanced HCC Patients: an Open, Single Arm, Phase II Clinical TrialStatus: Completed, Estimated PCD: 2022-09-01
Clinical trial
Phase I Clinical Study of GC012F Injection in Treatment of Refractory Systemic Lupus ErythematosusStatus: Recruiting, Estimated PCD: 2023-10-19
Clinical trial
A Phase 1 Study of Evaluating Preliminary Safety and Efficacy of CT101a in the Treatment of Relapsed or Refractory (r/r) AML PatientsStatus: Terminated, Estimated PCD: 2022-08-28
Clinical trial
Comparison of With and Without Sequential Single Drug Therapy of S-1 After Adjuvant Chemotherapy With Docetaxel Plus S-1 in Stage III Gastric CancerStatus: Recruiting, Estimated PCD: 2026-12-31
Clinical trial
18F-FAPI PET/CT and 18F-FDG PET/CT in Patients With Pancreatic Adenocarcinoma : A Prospective, Single-Center, Comparative StudyStatus: Completed, Estimated PCD: 2023-02-28
Clinical trial
A Phase II Study to Explore the Neoadjuvant Treatment of Serplulimab Combined With CAPEOX + Celecoxib in the Treatment of Locally Advanced Rectal CancerStatus: Recruiting, Estimated PCD: 2024-02-20
Clinical trial
A Study on the Safety and Efficacy of Chimeric Antigen Receptor T Cells in the Treatment of Refractory Myasthenia GravisStatus: Recruiting, Estimated PCD: 2026-04-20
Clinical trial
A Study to Evaluate the Efficacy and Safety of CD7CAR-T Bridging to Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Refractory or Relapsed CD7 Positive Malignant Hematologic DiseasesStatus: Recruiting, Estimated PCD: 2025-04-25
Clinical trial
Clinical Study on the Safety and Effectiveness of Autologous Hematopoietic Stem Cell Transplantation Combined With CAR-T Cells in the Treatment of Refractory and Relapsed Multiple MyelomaStatus: Recruiting, Estimated PCD: 2025-03-01
Clinical trial
A Study of Chemotherapy With WeiLeShu Versus Chemotherapy Alone in Patients With Metastatic Colorectal CancerStatus: Completed, Estimated PCD: 2021-10-30
Clinical trial
A Phase I Clinical Study of 4th Generation Chimeric Antigen Receptor T Cells Targeting Glypican-3 ( CAR-GPC3 T Cells) in Patients With Advanced Hepatocellular CarcinomaStatus: Completed, Estimated PCD: 2020-12-30
Clinical trial
Clinical Trial for the Safety and Efficacy of BCMA CAR-T Cell Therapy for Newly Diagnosed Multiple MyelomaStatus: Recruiting, Estimated PCD: 2024-04-01
Clinical trial
NKG2D CAR-NK Cell Therapy for the Treatment of Patients With Relapsed and/or Refractory Acute Myeloid LeukemiaStatus: Recruiting, Estimated PCD: 2024-04-01
Clinical trial
An Exploratory Study of Tislelizumab in Combination With Oxaliplatin and Tegafur for the Treatment of Gastric Cancer With Liver MetastasesStatus: Recruiting, Estimated PCD: 2025-08-31
Clinical trial
Exploratory Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of UCLM802 (Anti-Mesothelin CAR-T) Cell Injection in Patients With Mesothelin-positive Advanced Malignant Solid TumorsStatus: Recruiting, Estimated PCD: 2025-05-01
Clinical trial
SHR-1210 Combined With Apatinib Mesylate in the Perioperative Therapy for Technically Resectable Hepatocellular CarcinomaStatus: Recruiting, Estimated PCD: 2024-06-30
Clinical trial
Clinical Trial of Autologous GPC3 CAR-T Cells (CBG166) Therapy for Advanced Hepatocellular CarcinomaStatus: Not yet recruiting, Estimated PCD: 2027-07-01
Clinical trial
A Single-center, Single-arm, Open-label, Dose-escalation Clinical Study to Evaluate the Safety and Anti-tumor Efficacy of Intratumoral NKG2D CAR-NK Cell Injection Guided by EUS in the Treatment of Locally Advanced Pancreatic Cancer.Status: Not yet recruiting, Estimated PCD: 2025-06-30